A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Study acronym: LUMA-PSMA
StatusActive, Not Recruiting
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Final enrollment: 15 participants (planned 10)
  2. Enrollment closed, study ongoing Show 4 more changesShow less
    • Study completion moved earlier from Dec 30, 2026 to Nov 30, 2026
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 3 of 3 entries
    • Eligibility criteria expanded, about 4 words
  3. Recruitment openedv6 Show 4 more changesShow less
    • Primary completion pushed from Sep 30, 2026 to Oct 30, 2026
    • Study completion pushed from Nov 30, 2026 to Dec 30, 2026
    • Study sites: 3 to 2
    • Start date changed from estimate of Jun 5, 2026 to Jul 1, 2026
  4. Primary completion pushed from Mar 31, 2026 to Sep 30, 2026
    • Start date: Feb 1, 2026 to Jun 5, 2026
    • Study completion pushed from Jun 30, 2026 to Nov 30, 2026
    v5
  5. Start date: Dec 2025 to Feb 1, 2026
    • Primary completion date: Mar 2026 to Mar 31, 2026
    • Study completion date: Mar 2026 to Jun 30, 2026
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jun 2025 to Dec 2025
    • Study sites: 2 to 3
    • Primary completion date: Dec 2025 to Mar 2026
    v3
  2. Study sites: 1 to 2v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Trial Details
NCT Number NCT06906471
Lead Sponsor Antelope Surgical Solutions, Inc
Conditions
(from sponsor)		 Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging
Related terms Adenocarcinoma, Prostatic Neoplasms
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov